CID is 4628
synonyms found at PubChem are:
oxolinic acid, 14698-29-4, Nidantin, Dioxacin, Emyrenil, Prodoxal, Prodoxol, Gramurin, Oksaren, Oxolinic, Ossian, Uroxol, Utibid, Uritrate, Urotrate, Oxoboi, Pietil, Starner, Ultibid, Acido oxolinico, Acide oxolinique, Uro-alvar, Acidum oxolinicum, Cistopax, Orthurine, Tiurasin, Acido ossolico, 5-Ethyl-8-oxo-5,8-dihydro-[1,3]dioxolo[4,5-g]quinoline-7-carboxylic acid, NSC-110364, Urinox, Acido ossolico [DCIT], 1-Ethyl-6,7-methylenedioxy-4-quinolone-3-carboxylic acid, UNII-L0A22B22FT, 5-Ethyl-8-oxo-5,8-dihydro[1,3]dioxolo[4,5-g]quinoline-7-carboxylic acid, W 4565, NSC 110364, Acide oxolinique [INN-French], Acido oxolinico [INN-Spanish], Acidum oxolinicum [INN-Latin], CCRIS 6301, HSDB 3243, 1-Ethyl-1,4-dihydro-6,7-methylenedioxy-4-oxo-3-quinolinecarboxylic acid, 5-Ethyl-5,8-dihydro-8-oxo-1,3-dioxolo(4,5-g)quinoline-7-carboxylic acid, EINECS 238-750-8, BRN 0620635, 1,3-Dioxolo[4,5-g]quinoline-7-carboxylic acid, 5-ethyl-5,8-dihydro-8-oxo-, L0A22B22FT, C13H11NO5, 5-ethyl-8-oxo-[1,3]dioxolo[4,5-g]quinoline-7-carboxylic acid, CHEBI:138856, KYGZCKSPAKDVKC-UHFFFAOYSA-N, S-0208, 1,3-Dioxolo(4,5-g)quinoline-7-carboxylic acid, 5-ethyl-5,8-dihydro-8-oxo-, NSC110364, NCGC00015762-06, CAS-14698-29-4, DSSTox_CID_1089, DSSTox_RID_75935, DSSTox_GSID_21089, W-108119, 5,8-Dihydro-5-ethyl-8-oxo-1,3-dioxolo[4,5-g]quinoline-7-carboxylic acid, 5-Ethyl-5,8-dihydro-8-oxo-1,3-dioxolo[4,5-g]quinoline-7-carboxylic acid, 5-ethyl-8-oxo-5-hydro-2H-1,3-dioxoleno[4,5-g]quinoline-7-carboxylic acid, SR-01000076042, Inoxyl, Oxolinic acid [USAN:BAN:INN], Oxolinic acid [USAN:INN:BAN], Aqualinic (TN), Prestwick_629, Spectrum_001397, AC1L1ILD, Prestwick0_000193, Prestwick1_000193, Prestwick2_000193, Prestwick3_000193, Spectrum2_000933, Spectrum3_001490, Spectrum4_000073, Spectrum5_001176, Lopac-O-0877, D00MAN, D0O7CL, AC1Q6E0J, Oxolinic acid (USAN/INN), Lopac0_000952, Oprea1_169598, SCHEMBL24445, BSPBio_000145, BSPBio_003079, KBioGR_000625, KBioSS_001877, MLS000028501, DivK1c_000659, SPECTRUM1502030, SPBio_000866, SPBio_002066, BPBio1_000161, CHEMBL416755, ZINC1875, Jsp002720, DTXSID1021089, HMS502A21, KBio1_000659, KBio2_001877, KBio2_004445, KBio2_007013, KBio3_002579, KS-00000GUT, AOB5349, MolPort-000-885-505, NINDS_000659, HMS1568H07, HMS1921F12, HMS2092P09, HMS2095H07, HMS3262P06, HMS3712H07, Oxolinic acid, analytical standard, Pharmakon1600-01502030, Oxolinic acid, quinolone antibiotic, ACT03284, GRC-6127, GRC-6211, HY-B1002, Tox21_110216, Tox21_202787, Tox21_500952, 5-ethyl-8-oxo-5,8-dihydro[1,3]dioxolo[4,5-g]chinolin-7-carbons, BBL009934, BN0853, CCG-39666, GA2313, MFCD00056775, NSC758177, s4537, SBB012469, STK801351, AKOS000282622, Tox21_110216_1, API0003716, CS-4499, LP00952, LS-7635, MCULE-2131347036, NSC-758177, IDI1_000659, NCGC00015762-01, NCGC00015762-02, NCGC00015762-03, NCGC00015762-04, NCGC00015762-05, NCGC00015762-07, NCGC00015762-08, NCGC00015762-09, NCGC00015762-10, NCGC00015762-11, NCGC00015762-13, NCGC00093361-02, NCGC00093361-03, NCGC00093361-04, NCGC00093361-05, NCGC00260333-01, NCGC00261637-01, AJ-08105, AK117020, AN-17428, AS-12087, CC-33419, SMR000058314, ST067125, SBI-0050926.P003, TRPV1 antagonists (pain), Glenmark/Lilly, AB1009279, AX8014601, DB-042865, KB-245869, EU-0100952, FT-0637128, ST24029466, T7411, TRPV1 antagonists (asthma), Glenmark/Lilly, VU0243182-3, C11342, D02301, O 0877, WLN: T C566 DO FO JN MV EHJ J2 LVQ, 698O294, C-16314, TRPV1 antagonists (incontinence), Glenmark/Lilly, I14-7471, SR-01000076042-1, SR-01000076042-4, SR-01000076042-6, BRD-K73394555-001-08-6, 5-Ethyl-5,3-dioxolo[4,5-g]quinoline-7-carboxylic acid, F3351-0487, 1-Ethyl-1,7-methylenedioxy-4-oxo-3-quinolinecarboxylic acid, Oxolinic acid, European Pharmacopoeia (EP) Reference Standard, 1,5-g]quinoline-7-carboxylic acid, 5-ethyl-5,8-dihydro-8-oxo-, 1.4-Dihydro-1-ethyl-6,7-methylenedioxy-4-oxoquinoline-3-carboxylic acid, 5-Ethy1-5,8-dihydro-8-oxo-1,3-dioxolo[4,5]quinoline-7-carboxylic acid, 5-Ethyl-8-oxo-5,8-dihydro-[1,3]dioxolo[4,5-g]quinoline-7-carboxylicacid, Transient receptor potential vanilloid sub-family 1 (pain), Glenmark/ Lilly, 5-ETHYL-8-OXO-2H,5H,8H-[1,3]DIOXOLO[4,5-G]QUINOLINE-7-CARBOXYLIC ACID, 5-Ethyl-8-oxo-5,8-dihydro[1,3]dioxolo[4,5-g]quinoline-7-carboxylic acid #, Vanilloid receptor VR1 antagonists (incontinence/pain/asthma), Glenmark/Lilly, W-4565; 5,8-Dihydro-5-ethyl-8-oxo-1,3-dioxolo[4,5-g]quinoline-7-carboxylic acid, InChI=1/C13H11NO5/c1-2-14-5-8(13(16)17)12(15)7-3-10-11(4-9(7)14)19-6-18-10/h3-5H,2,6H2,1H3,(H,16,17